The herpes simplex virus 1 virion protein 16 (VP16) tegument protein forms a transactivation complex with the cellular proteins host cell factor 1 (HCF-1) and octamer-binding transcription factor 1 (Oct-1) upon entry into the host cell. VP16 has also been shown to interact with a number of virion tegument proteins and viral glycoprotein H to promote viral assembly, but no comprehensive study of the VP16 proteome has been performed at early times postinfection. We therefore performed a proteomic analysis of VP16-interacting proteins at 3 h postinfection. We confirmed the interaction of VP16 with HCF-1 and a large number of cellular Mediator complex proteins, but most surprisingly, we found that the major viral protein associating with VP16 is the infected cell protein 4 (ICP4) immediate-early (IE) transactivator protein. These results raise the potential for a new function for VP16 in associating with the IE ICP4 and playing a role in transactivation of early and late gene expression, in addition to its well-documented function in transactivation of IE gene expression.
Introduction
Multiple approaches have been used to define viral protein function, including genetic, biochemical, and proteomic analyses. Genetic analysis involves the isolation of mutant viruses and the definition of the phenotype of the mutant virus, which can define the function(s) of the mutant viral protein. The phenotype of a mutant virus, however, can be due to direct or indirect effects of the absence of the viral gene product. Biochemical analysis can identify enzymatic or other biochemical properties of a viral protein, but this does not always define the function of the protein. Proteomic analysis involves the identification of the proteins that associate directly or indirectly with a specific viral protein, and this analysis can provide new information about the function of the viral gene product. Viral proteomics has illuminated several new protein functions including: tumor suppressor proteins such as Rb and p53, which interact with simian virus 40 [1-4], adenovirus [5] [6] [7] , and papilloma virus [8, 9] tumor antigens; adaptor proteins such as the E6AP protein that links a target protein to an E3 ubiquitin ligase [10] ; and the role of host cell DNA repair and recombination proteins in viral DNA replication [11] . Viral proteomic studies are often conducted in cells overexpressing a viral protein, but the activities of proteins when overexpressed may not be the same as in infected cells. For example, the herpes simplex virus (HSV) infected cell protein (ICP) 27 protein shows repressive activities in transfected cells [12] [13] [14] , while genetic studies in infected cells have largely revealed transactivator functions for ICP27 [15] [16] [17] . Therefore, it is important to study the proteomics of viral proteins in infected cells where the authentic functions of the viral proteins are being carried out. Proteomic studies of viral proteins in infected cells have been very informative and raised new roles for viral and cellular proteins in viral replication [11, 18] .
HSV has a double-stranded DNA genome that is transcribed by the cellular RNA polymerase II in the infected cell nucleus and utilizes host transcription mechanisms for its gene expression. Transcription of eukaryotic protein-coding genes is catalyzed by the RNA polymerase II holoenzyme, which requires, at the minimum, multiple general transcription factors (RNA polymerase II, TFIIA, TFIIB, TFIID,  TFIIE, TFIIF, and TFIIH) . These proteins are assembled into the preinitiation complex (PIC). However, the PIC requires diverse transcriptional cofactors to regulate individual gene transcription, including gene-specific activators and the Mediator complex. Initially, the Mediator complex was considered to provide a connection between the activators and PIC for their communication and stability of the DNA-PIC [19] [20] [21] [22] [23] . A wealth of evidence from recent studies has expanded our understanding of the functional roles of the Mediator to include epigenetic regulation [24] [25] [26] [27] , super enhancer formation [28, 29] , transcriptional elongation [30] [31] [32] , transcription termination [33] , and mRNA processing [33, 34] . Furthermore, multiple subunits of Mediator are known to be targets of diverse signal transduction pathways [35] [36] [37] , and mutations in genes encoding Mediator subunits have been related to human diseases (refs in [38] ). Therefore, the Mediator complex plays the role of a control hub to regulate transcription in diverse biological situations.
HSV gene expression occurs in a cascade fashion with immediate-early (IE) gene expression leading to early (E) gene expression, which leads to DNA replication, which leads to late (L) gene expression [39] . During lytic infection, efficient IE gene transcription is critical for the subsequent E and L gene transcription [40] . IE gene transcription is transactivated by complexes of viral and host proteins binding to IE gene promoter elements involving the HSV virion protein 16 (VP16) binding to the cellular proteins host cell factor 1 (HCF-1) and octamer-binding transcription factor 1 (Oct-1) to form a transactivator complex, which binds to the cis-regulatory consensus sequence, TAATGARAT (where R is purine), in the upstream sequences of the HSV IE genes. VP16 interacts directly with transcriptional activators and interacts indirectly with epigenetic factors through HCF-1. VP16 has a core region and C-terminal transcriptional activation domain (TAD). The core region is sufficient for VP16-induced transactivator complex formation [41, 42] , and the TAD is known to be critical for activation of transcription. This transactivation is induced by interactions with multiple general transcription factors including TATA-binding protein [43] , transcription factor (TF) IIA [44] , TFIIB [45] , TFIID [46, 47] , and TFIIH [48] . In addition, the VP16 TAD interacts with subunits of Mediator [49] [50] [51] , implying a direct role in the regulation of the RNA polymerase II machinery. HCF-1 contributes to epigenetic modifications for IE gene transcription by recruiting many epigenetic regulating factors [40] . Upon entry of the HSV genome into the nucleus, histones are associated with the viral genome, and initial viral gene transcription depends on cellular epigenetic regulation. To facilitate IE gene transcription, HCF-1 recruits histone methyltransferase (SETD1A and MLLs) [52] , demethylases (KDM1A and KDM4s) [53, 54] , and histone chaperone HIRA [55] , and Asf1s [56] . The HSV IE ICP0 then promotes the reduction in chromatin loading, the removal of heterochromatin marks [57] (Raja, Lee, and Knipe, manuscript in preparation), and the addition of euchromatin marks on the E and L genes [58] . The HSV ICP4 transactivator promotes the assembly of the PICs on viral E and L promoters [59, 60] and transcription of E and L genes [61] [62] [63] . ICP4 interacts with components of the basal TFIID and the Mediator complex to promote the formation of the transactivational PIC [59, 64, 65] .
The VP16 TAD has been shown to interact with three subunits (MEDs) of Mediator, MED15, MED17, and MED25 [49-51, 66, 67] . However, these studies used the VP16 TAD domain alone, which could limit the binding partners that are identified. Furthermore, these studies were performed using purified or overexpressed tagged TAD, and none of these studies identified VP16 binding partners during the HSV lytic infection. In addition, little is known about which host factors are associated with VP16 in the cytoplasm during HSV lytic infection. Therefore, we hypothesized that full-length VP16 might interact with more diverse cellular proteins during the HSV lytic infection, which could provide insight into other functions of VP16.
Epitope tags have been used to facilitate affinity purification of proteins [68] . Green fluorescence protein (GFP) has also been established as a tag to study protein interactions [69] and recombinant viruses expressing GFP-fused viral proteins have been used to characterize virus-host and virusvirus protein interactions using MS [70] [71] [72] demonstrating GFP can be an effective tool for proteomic studies. Furthermore, in our case, fusion of GFP to VP16 has little or no effect on HSV-1 lytic infection [73, 74] implying that the GFP-fused VP16 is similar to the native VP16.
We therefore performed MS analysis on VP16-GFP immunoprecipitates from HSV-infected cells at early times postinfection. We confirmed the interaction of VP16 with the Mediator complex, but, most surprisingly, the major viral protein found in the immunoprecipitates was ICP4, the major IE transactivator. This observation raises the possibility that VP16 plays a role in the transactivation of E and L genes as well as IE gene expression.
Materials and methods

Cells and viruses
U2OS, human foreskin fibroblast (HFF), and Vero cells were obtained from the American Type Culture Collection (Manassas, VA). U2OS cells were maintained in DMEM (Life Technologies, Carlsbad, CA) supplemented with 5% v/v FBS, 5% v/v BCS and 2 mM L-glutamine in 5% CO 2 . The HSV-1 KOS wild-type (WT) strain [75] and VP16-GFP fusion HSV-1 DG1 virus [73] were titrated on Vero cells. Viruses were diluted in PBS containing 0.1% glucose w/v, 0.1% BCS (v/v) and incubated with cells for 1 h with shaking at 37ЊC followed by replacing media with DMEM containing 1% BCS and incubation at 37ЊC.
Immunoprecipitation
U2OS cells (1 × 10 8 ) or HFF cells (2 × 10 7 ) were infected with HSV-1 WT or DG-1 virus at a multiplicity of infection (MOI) of 50, washed with PBS twice at 3 h postinfection (hpi), and harvested in PBS supplemented with protease cocktail inhibitor (Roche, Penzberg, Upper Bavaria, Germany). The cells were collected by centrifugation at 1000 × g at 4ЊC for 5 min. The cells were lysed by incubation on ice for 30 min in 2 mL of NP-40 lysis buffer (0.5% NP-40, 10% glycerol, 50 mM Tris pH 7.5, 50 mM NaCl, 50 mM NaF, 0.5 mM dithiothreitol, and 1× Complete protease inhibitors cocktail (Roche)). The lysates were clarified by centrifugation at 1000 × g at 4ЊC for 10 min, and the cytoplasmic fraction was saved on ice. The pellets were resuspended in 0.8 mL of NP-40 lysis buffer again, sonicated to disrupt the nuclei using a Bioruptor (Diagenode, Denville, NJ) for 30 s at maximum amplitude, and clarified by centrifugation at maximum speed at 4ЊC for 10 min. The cytoplasmic and soluble nuclear fractions were combined, and immunoprecipitation was performed by incubation of 0.5 mL of MACS anti-GFP MicroBeads (MACS, Bergisch Gladbach, Germany) or anti-GFP mAb-Magnetic beads (MBL, Woburn, MA) with the lysate at 4ЊC for 4 h followed by four washes with NP-40 lysis buffer. Proteins were eluted from the beads using Laemmli sample buffer, boiled for 10 min, and resolved by SDS-PAGE.
SDS-PAGE, silver staining, and immunoblotting
For initial characterization of the immunoprecipitates, onetenth of the immunoprecipitated samples was resolved in NuPAGE 4-12% Bis-Tris Gels (Life Technologies), and silver staining was performed using the Pierce Silver Stain Kit for Mass Spectrometry (ThermoFisher Scientific, Waltham, MA) following the manufacturer's protocol. For immunoblotting, resolved samples were transferred to nitrocellulose membranes (Bio-Rad, Hercules, CA). The membranes were blocked with Odyssey Blocking Buffer (LI-COR, Lincoln, NE) and incubated with antibodies specific for HSV ICP4 (1:4000, mAb 58S [76] , HSV ICP8 (1:5000, rabbit serum 3-83 [77] ), GFP (1:2000, rabbit serum, Abcam, Cambridge, MA), VP5 (1:2000, mAb, EastCoast, North Berwick, ME), and GAPDH (1:10000, mAb, Abcam). The membranes were incubated with secondary antibodies IRDye 680RD and IRDye 800 (LI-COR) for 45 min and near-infrared fluorescence was detected using Odyssey (LI-COR).
Mass spectrometry
Immunoprecipitated samples were resolved in SDS-PAGE gels, and proteins were stained with Coomassie Brilliant Blue G-250 (PIERCE, Waltham, MA). The lane of the gel was divided into two sections, one larger than 75 kDa and the other smaller than 75 kDa, and subjected to a modified in-gel trypsin digestion [78] . The gel pieces were washed and dehydrated with acetonitrile for 10 min and completely dried. The gel pieces were then rehydrated with trypsin solution (50 mM ammonium bicarbonate and 12.5 ng/L modified sequencing-grade trypsin (Promega, Madison, WI)) at 4ЊC for 45 min, and the trypsin solution was replaced with sufficient fresh trypsin solution to cover the gel pieces. The gel pieces were incubated at 37ЊC overnight. The trypsin digest solution was collected, and the gel pieces were washed with washing solution (50% acetonitrile and 1% formic acid) once. The peptide-extracted trypsin solution and the wash were combined and lyophilized in a speed vac. The dried samples were reconstituted in HPLC solvent A (2.5% acetonitrile and 0.1% formic acid), and peptides were eluted using a fused silica capillary with an increasing concentration of gradient solvent B (up to 97.5% acetonitrile and 0.1% formic acid). The eluted peptides were detected using a LTQ Velos ion-trap mass spectrometer (ThermoFisher, Scientific) and peptide sequences were analyzed to identify proteins using protein databases with the acquired fragmentation pattern by the software program, Sequest (ThermoFisher, Scientific) [79] at the Taplin Biological Mass Spectrometry Facility, Harvard Medical School.
Bioinformatic analysis
We prepared the VP16-interacting protein network using BioGrid and VirHostNet databases. The VP16-interacting protein networks were merged and reconstructed including our hits using Cytoscape 3.2.0. [80] . We performed GO analysis with our hits using ClueGO databases [81] in Cytoscape.
Default parameters were used to analyze GO of molecular function.
Results
Identification of VP16-interacting proteins using an HSV-1 recombinant virus expressing VP16-GFP
To identify VP16-interacting proteins at early times postinfection, we performed proteomic analysis using the HSV-1 DG1 virus, which expresses VP16-GFP, for infection of U2OS cells. U2OS cells were used in the initial studies because they show a strong dependence on VP16 for viral gene expression [82] . In two independent experiments, we infected U2OS cells with DG1 virus at an MOI of 50 and harvested the infected cells at 3 hpi. We have used this MOI in previous studies to allow detection of input virion VP16 by immunoblotting and immunofluorescence [83] . The cells were lysed, and immunoprecipitation was performed with an anti-GFP antibody as described in Section 2. To validate the immunoprecipitates, aliquots (one-tenth) of the immunoprecipitated samples were resolved by SDS-PAGE, and protein bands were visualized using silver staining. DG1-virus infected cell immunoprecipitates showed a specific band of VP16-GFP and a number of other bands not observed in the WT virus-infected lysate (Fig. 1) . To identify the VP16-GFP interacting proteins, the remaining portions of the samples were analyzed by microcapillary LC-MS/MS as described in Section 2. This analysis identified over 200 proteins from the immunoprecipitates of DG1 virus-infected cell lysates. To define the most significant hits, we considered only proteins that were detected in VP16-GFP immunoprecipitates from each of the two biological duplicate experiments and as at least two unique peptides in one of the immunoprecipitates. We also found O-glycosyl transferase (OGT), which is known to interact with HCF-1 [90] , two vesicle-associated proteins (VAPA and VAPB), three 14-3-3 proteins (YWHAB, YWHAQ, and YWHAZ), and one heterogeneous ribonucleoprotein, hn-RNP3A. Therefore, the analysis confirmed the interaction of VP16 with the Mediator complex and identified one hnRNP protein, raising a potential role for VP16 in loading hnRNP proteins on nascent transcripts for export from the nucleus.
To search for HSV proteins that interacted with VP16, we used the Uniprot database (ID no. 10298) to identify HSV peptides in the immunoprecipitates. Using the criteria of more than two unique peptides in the VP16-GFP immunoprecipitates in both experiments but none in the control immunoprecipitates, we identified 19 HSV proteins including seven previously identified proteins (Table 2 and Fig. 2A) . The majority of these were virion structural proteins, four capsid proteins (U L 19/VP5, U L 18/VP23, U L 38/VP19C, and U L 25), ten tegument proteins (U L 49/VP22, U L 36/VP1/2, U L 41/vhs, U L 47/VP13/14, U L 46/VP11/12, U S 10, U L 13, U S 2, U L 55, and U S 3), and one assembly protein (U L 55). Nonstructural proteins included ICP6, the U L 12 nuclease, ICP0, and thymidine kinase, but, surprisingly, the most abundant protein was ICP4, the major IE transactivator. Therefore, the analysis in the infected cells at early times postinfection showed a new viral protein-protein interaction, that of VP16 with ICP4.
We performed functional analysis of VP16-interating proteins based on GO annotations using ClueGO database (Fig.  2B) . The analysis classified functional roles of VP16 in transcriptional activity, nuclear receptor binding activity, and acetyltransferase activity, which confirmed the previously known functions of VP16-asscoiated complexes. Therefore, this analysis validates our proteomic approach to identify VP16-interacting proteins.
Validation of VP16-interacting proteins
To validate the viral protein hits, we performed immunoprecipitation and immunoblotting with extracts from a different human cell type, HFFs. HFF cells were infected with DG1 virus at an MOI of 50 and harvested at 3 hpi. VP16-GFP was immunoprecipitated with anti-GFP antibody, and ICP4, VP5, and ICP8 were detected using their cognate antibodies. ICP4 and VP5 were detected in the VP16-GFP immunoprecipitates (Fig. 3A) . However, ICP8 did not coimmunoprecipitate with VP16 (Fig. 3A) , demonstrating the specificity of the coimmunoprecipitation. Reciprocal immunoprecipitation experiments also showed that VP16 coimmunoprecipitated with ICP4 (Fig. 3B) . Therefore, these results confirmed that analysis of VP16 interactors at early times postinfection identified novel VP16-interacting proteins.
Discussion
Viral proteins can show different activities in infected cells as compared with cells in which the proteins are overexpressed in short-term transfected or stably transformed cells; therefore, it is important to study the properties and functions of viral proteins in infected cells where there are authentic levels of viral proteins. The HSV-1 VP16 protein has been shown to bind to the cellular HCF-1 and octamer-binding transcription factor 1 proteins to form a transactivator complex that binds in the promoter/regulatory regions of viral IE genes and activate their transcription. At early times postinfection, VP16 is known to interact with the Mediator complex and TFIID subunits to promote IE gene transcription. At late times, newly expressed VP16 is known to interact with other tegument proteins and assemble into progeny virions. Thus, there is some information about proteins that interact with VP16; however, there has not been a comprehensive analysis of proteins interacting with VP16, in particular at very early times postinfection. In this study, we examined the cellular and viral proteins interacting with VP16 at 3 hpi. We found the cellular Mediator proteins and viral tegument proteins previously shown to interact with VP16. We also found capsid proteins coprecipitating with VP16, possibly via incompletely uncoated capsids coprecipitating with anti-VP16 antibody. Most significantly, we found that the major viral protein coprecipitating with VP16 at 3 h postinfection was ICP4, the viral major IE transactivator protein. This raises the new idea that VP16 may cooperate with ICP4 to transactivate E gene expression at these very early times.
Interaction of VP16 with virion proteins
VP16, as a component of the tegument layer of the HSV virion, is known to interact with a number of virion proteins including the VP11/12 tegument proteins [91] , the VP13/14 tegument proteins [91] , vhs/U L 41 tegument protein [92, 93] , and VP22/U L 49 tegument protein [93] as well as glycoprotein H in the envelope [94] . Based on the interactions of VP16 with both tegument proteins and gH, VP16 has been proposed to play a role with VP22 in budding of the nucleocapsid through the nuclear membrane [95] . In this study, we also saw capsid proteins coprecipitating with VP16 but no gH. This difference may be due to the early time that we studied, at which time we may be detecting the disassembling input virions rather than assembling virions at the later times used in other studies [94] . These results suggest that VP16 may interact with directly or indirectly with the capsid.
Interaction of VP16 with the Mediator complex
Previous studies had shown that VP16 or portions of it interact with Mediator complex subunits [49-51, 66, 67] . These earlier studies were done with the isolated VP16 transactivation domain or in transfected or stably transformed cells. Thus, it is important that we have confirmed this interaction in HSV-infected cells, showing that VP16 interacts with the Mediator complex in infected cells, because this shows it is an authentic interaction in infection.
Interaction of VP16 with ICP4
The most surprising observation was that the major HSV protein coprecipitating with VP16 at 3 h postinfection is ICP4, the IE transactivator of E and L gene transcription [61] [62] [63] . VP16 is known to promote the expression of ICP4, but there is no evidence that they function together in any way; however, the interaction observed in our studies argues that they may function together to transactivate E and L gene expression. We hypothesize that ICP4 may bind to viral DNA and tether VP16 to the viral E gene promoters, promoting their transcription. ICP4 is known to associate with the Mediator complex [65, 96] ; thus, the interaction of VP16 with ICP4 may be indirect through Mediator. Alternatively, ICP4 and Mediator may each interact directly with VP16. Further studies are needed to determine if VP16 interacts directly with ICP4. If so, mapping of the portions of the two proteins needed for the interaction will be informative. Cotransfection studies will be performed to determine if the two viral proteins cooperate in transactivation of E promoters such as the ICP8/U L 29 gene promoter as observed previously for ICP4 and ICP0 [97] . This may provide a new target for antivirals that block HSV replication and/or reactivation. Thus, screens for small molecules that inhibit the cooperation between VP16 and ICP4 could lead to new antiviral inhibitors of HSV. [5] Sarnow, P., Ho, Y. S., Williams, J., Levine, A. J., Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 1982, 28, 387-394.
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